0518 (0518) Fair Value & Analysis

Consumer Cyclical · Market cap HK$97.9M

0 0518 0518 · HK

PriceHK$0.2170

Fair ValueHK$0.0400

Upside-81.6%

Quality59/100

Evidence: Low Range HK$0.0400 – HK$0.0500

Fair value as of: Jul 1, 2026

From 3 valuation models · updated today

Share price +10.2% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.1800 – HK$0.2600 · fair‑value band HK$0.0400 – HK$0.0500 · the HK$0.2170 price screens above the HK$0.0400 fair value. As of Jul 1, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0518 (0518) currently trades at HK$0.2170, while our model-based Fair Value estimate is HK$0.0400 — implying the stock looks roughly 81.6% overvalued today. We read business quality at 59/100 (solid quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 0518 generated revenue of HK$567M at a net margin of -2.7%. Revenue declined 17.0% year over year. It earns a return on equity of -4.3%. The balance sheet holds a net cash position of HK$186M. Fundamentals as of Jul 1, 2026

Key figures & financial health

Revenue (TTM) HK$567M

Revenue growth (YoY) -17.0%

Net margin -2.7%

Return on equity -4.3%

Free cash flow −HK$47.4M FY2025

Operating margin -3.3%

More key figures

EPS (TTM) HK$-0.0100

EPS growth (YoY) +128%

Net cash HK$186M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

0518 reported revenue of HK$567M in FY2026 versus HK$588M in FY2022, a compound −0.9%/yr. Reported net income was −HK$15.0M in FY2026.

Revenue −0.9%/yr

FY22 HK$588M

FY23 HK$753M

FY24 HK$517M

FY25 HK$669M

FY26 HK$567M

Net income

FY22 −HK$26.1M

FY23 HK$19.7M

FY24 −HK$12.8M

FY25 −HK$9.9M

FY26 −HK$15.0M

Is 0518 fairly valued? → Check now

Similar stocks

6 more Apparel Manufacturing stocks, each showing price versus our Fair Value estimate (as of Jul 1, 2026).

Stock	Price	Fair Value	vs Fair Value
H & M Hennes & Mauritz AB HMB	kr 166.80	kr 165.47	-1%
Ralph Lauren Corporation RL	$366.55	$365.78	-0%
Moncler S.p.A MONRY	$61.42	$42.18	-31%
Gildan Activewear Inc GIL	$58.41	$37.01	-37%
LPP SA LPP	18,350 PLN	20,063 PLN	+9%
Levi Strauss & Co LEVI	$22.95	$14.47	-37%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0518 (0518) undervalued?

As of Jul 1, 2026, our model estimates a fair value of HK$0.0400 versus a price of HK$0.2170 — about −82% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 0518?

Our model-based fair value for 0518 is HK$0.0400 (as of Jul 1, 2026), built from audited fundamentals. The current price is HK$0.2170.

What is the quality score of 0518?

0518 has a Quality Score of 59/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0518 (0518)?

0518 reported trailing-twelve-month revenue of about HK$567M (latest available figure, as of Jul 1, 2026).

What is the net profit margin of 0518?

The net profit margin of 0518 is about -2.7%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.